GoodRx Tracker reveals inflation’s toll on prescriptions and consumer essentials
Prescription medications have seen the highest inflation compared to other medical goods, like nonprescription medications and medical equipment.
GoodRx
New report from GoodRx tracks changes in GLP-1 insurance coverage
In 2025, the number of people without commercial insurance coverage for these medications surged significantly. Zepbound saw a 14% increase since 2024, leaving 4.9 million people without coverage, and Ozempic saw a 22% increase, affecting another 1.1 million people.